SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

14 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 4521.71 millions rose by 31.40% from Rs. 3441.25 millions.The Total Profit for the quarter ended December 2023 of Rs. 15.65 millions grew from Rs.-92.89 millionsOP of the company witnessed a marginal growth to 426.70 millions from 146.85 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4521.71 3441.25 31.40 12442.56 11357.95 9.55 15246.09 16682.56 -8.61
Other Income 4.80 132.40 -96.37 115.61 243.14 -52.45 422.39 112.93 274.03
PBIDT 426.70 146.85 190.57 1161.57 602.04 92.94 979.02 1701.31 -42.45
Interest 248.41 174.64 42.24 629.82 598.18 5.29 794.77 788.10 0.85
PBDT 178.29 -27.79 -741.56 531.75 3.86 13675.91 184.25 913.21 -79.82
Depreciation 153.74 147.84 3.99 460.18 442.70 3.95 591.19 569.68 3.78
PBT 24.55 -175.63 -113.98 71.57 -438.84 -116.31 -406.94 343.53 -218.46
TAX 8.90 -82.74 -110.76 27.54 -160.63 -117.14 -182.37 90.34 -301.87
Deferred Tax 8.90 -82.74 -110.76 27.54 -160.63 -117.14 -182.37 90.34 -301.87
PAT 15.65 -92.89 -116.85 44.03 -278.21 -115.83 -224.57 253.19 -188.70
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 8.31 3.80 118.92 9.34 5.30 76.12 5.60 8.84 -36.61

Nectar Lifesciences Share Price

11.94 0.12 (1.02%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×